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L01.

Loss of Telomere-Associated Rap1 Precipitates Cardiac
Aging in Mice via P53/PPARα Signaling
Yin Cai 1, Zhengyuan Xia 2
1
Department of Health Technology and Informatics, The Hong Kong
Polytechnic University, Hong Kong SAR
2
State Key Laboratory of Pharmaceutical Biotechnology, LKS Faculty of
Medicine, The University of Hong Kong, Hong Kong SAR
Background: Telomere dysfunction has been linked to many aspects of
the aging process. Increasing evidence indicates that telomere
dysfunction leads to cardiac mitochondrial defects in mice. Mammalian repressor activator protein 1 (Rap1) is one of the components of
shelterin complex and essential for the maintenance of telomere length
and structural integrity. Our preliminary work showed that aged Rap1
knockout (Rap1-/-) mice exhibit more pronounced aging-associated
phenotypes. However, the effects of Rap1 on mitochondrial function
and its contribution to cardiac aging are largely unknown. Thus, the
present study investigated if loss of Rap1 precipitates cardiac aging
and explored the underlying mechanisms.
Methods and Results: Deletion of Rap1 aggravated aging-related
cardiac structural changes and dysfunction, as evidenced by
increased left ventricular (LV) posterior wall end-diastole and LV
mass, reductions in ejection fraction and fractional shortening, as
well as signiﬁcantly impaired myocardial performance index. These
changes were associated with greater cardiac senescence, cardiac
hypertrophy, abnormalities in the mitochondrial ultrastructure.
Mechanistically, Rap1 deﬁciency leads to shorter telomere, enhanced
DNA damage and increased nuclear p53 level in the heart and primary cardiomyocytes when compared to age-matched counterparts
(one year old). Chromatin immunoprecipitation assay revealed p53
directly bind the promote site of PPARα and repressed its expression.
Indeed, Rap1 deﬁciency in mice exhibited impaired fatty acid
metabolism [reduced CD36, CPT1α, ACADL level and palmitateinduced oxygen consumption], while in vivo PFTα (a p53 inhibitor,
i.p. 1.1 mg/kg/day) treatment in Rap1-/- mice signiﬁcantly alleviated
cardiac aging and enhanced fatty acid metabolism by restoration of
PPARα.
Conclusions With aging, Rap1 deﬁciency may lead to shorter telomere
length, increase DNA damage and thereby activate p53, which in turn
suppress the expression of PPARα, leading to impaired FAM and
mitochondrial defects, compromised cardiac structural and functional
changes. These ﬁndings identify a new cardiac dimension in the
physiological role played by telomere-Rap1.

L02.

Mature Human Pluripotent Stem Cells Derived
Cardiomyocytes to Investigate Cardiotoxicity Induced by
Anti Cancer and Anti-Viral Treatment
Ellen Poon 1
1
Department of Medicine & Therapeutics, Centre for Cardiovascular
Genomics & Medicine (CCGM), Hong Kong Hub of Paediatric Excellence
(HK HOPE), Faculty of Medicine, The Chinese University of Hong Kong,
Hong Kong SAR
Human (h) pluripotent stem cell (PSC)-derived cardiomyocytes (CMs)
are of signiﬁcant value to cardiac disease modelling, drug and cardiotoxicity testing, but their uses are limited by the immaturity of
hPSC-CMs and their inability to recapitulate some (patho)physiological attributes of adult CMs.
We recently showed that hPSC-CMs with more adult-like cardiac function can be isolated using CD36, a marker of cardiac maturation. CD36hi
CMs are phenotypically and functionally more mature than CD36lo CMs
and have signiﬁcantly increased sensitivities to chemical (H2O2), physiological (hypoxia/reoxygenation) and cardiotoxic (doxorubicin) stimuli.
Focused studies on doxorubicin-induced cardiotoxicity show that
CD36hi CMs, unlike mixed and CD36lo CMs, recapitulate known clinical
responses to cardioprotective drugs. This response has not been previously observed with unsorted hPSC-CMs, showing that CD36hi CMs
have drug responsive traits more consistent with an adult phenotype.
Additionally, we used our mature hPSC-CM platform to investigate
cardiotoxicity induced by antiviral treatment and showed that remdesivir, the only FDA-approved treatment against COVID-19, could induce
persistent mitochondrial and structural damage in hPSC-CMs.
In conclusion, our results demonstrate the importance of hPSC-CM
maturation for the accurate prediction of adult human responses, and
will greatly advance the use of hPSC-CMs for cardiac research.

L03.

Development of A Novel Strategy for Cell-Based Cardiac
Repair
Kiwon Ban1
Since both myocardium and vasculature in the heart are excessively
damaged following myocardial infarction (MI), therapeutic strategies
for treating MI hearts should concurrently target both so as to achieve
true cardiac repair. Here we demonstrate a concomitant method
that exploits the advantages of cardiomyocytes derived from
human induced pluripotent stem cells (hiPSC-CMs) and human
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Methods: A total of 439,142 and 1,773,283 individuals with at least one
valid blood pressure record and without CVD from the UK Biobank in
2006-2010 and from the electronic health record in Hong Kong in 20082017, respectively, were included. The CVD risks were compared
among participants in six groups of different blood pressure levels 1:
optimal (SBP <120 mmHg and DBP <80 mmHg); 2: normal (SBP 120129 mmHg and DBP 80-84 mmHg); 3: high normal (SBP 130-139
mmHg or DBP 85-89 mmHg); 4: grade 1 hypertension (SBP 140-159
mmHg or DBP 90-99 mmHg); 5: grade 2 hypertension (SBP 160-179
mmHg or DBP 100-109 mmHg); and 6: grade 3 hypertension (SBP 180
mmHg or DBP 110 mmHg)], as deﬁned by the ESC/ESH classiﬁcation. Cox regression adjusting with subject characteristics was performed in each cohort.
Results: After 4.5 and 10.9 million person-years follow-up, 23,132 and
147,093 incident CVD events were observed across all blood pressure
levels in the UK Biobank and Hong Kong cohort, respectively. Taking
the optimal blood pressure group as the reference, a positive association
between blood pressure levels and CVD risk was observed in both cohorts, with hazard ratios in ascending blood pressure groups being 1.07
(95% CI 1.00-1.13), 1.17 (95% CI 1.10-1.24), 1.32 (95% CI 1.25-1.39), 1.56
(95% CI 1.47-1.66), 1.91 (95% CI 1.76-2.06) in the UK Biobank, and 1.21
(95% CI 1.18-1.24), 1.25 (95% CI 1.22-1.28), 1.32 (95% CI 1.29-1.34), 1.60
(95% CI 1.56-1.65), and 2.07 (95% CI 1.96-2.18) in the Hong Kong cohort.
Conclusion: With consistent results from both cohorts, the relationship
between low blood pressure levels and reduced CVD risks is well
highlighted in this study, with the optimal group having the lowest risk
in multiple cardiovascular outcomes. Such ﬁndings provide the
grounds for reviewing the hypertension deﬁnition and optimal blood
pressure control in the current guidelines.

mesenchymal stem cell-loaded patch (hMSC-PA) to amplify cardiac
repair in a rat MI model. Epicardially implanted hMSC-PA provide a
complimentary microenvironment which enhances vascular regeneration through prolonged secretion of paracrine factors, but more
importantly it signiﬁcantly improves the retention and engraftment of
intramyocardially injected hiPSC-CMs which ultimately restore the
cardiac function. Notably, the majority of injected hiPSC-CMs display
adult CMs like morphology suggesting that the secretomic milieu of
hMSC-PA constitutes pleiotropic effects in vivo. We provide compelling evidence that this dual approach can be a promising means to
enhance cardiac repair on MI hearts.
L04.

Treatment with Direct Oral Anticoagulants or Warfarin
and the Risk for Incident Diabetes Among Patients with
Atrial Fibrillation
Ching-lung Cheung, Associate Professor 1
1
Department of Pharmacology and Pharmacy, The University of Hong
Kong, Hong Kong SAR
Background: Diabetes mellitus is a common comorbidity of atrial
ﬁbrillation (AF), which can complicate the management of AF. The
pharmacology of oral anticoagulants (OACs) have been implicated in
pathogenesis of diabetes, but the relationship between different OACs
and risk of diabetes remains unexamined. This study aimed to evaluate
the risk of diabetes with use of different OACs in AF patients.
Methods: Population-based retrospective cohort study using an electronic healthcare database managed by the Hong Kong Hospital Authority. Patients newly diagnosed with AF from 2014 through 2018 and
prescribed OACs were included and followed till December 31, 2019.
Inverse probability of treatment weighting based on the propensity
score (PS) is used to address potential bias due to nonrandomized
allocation of treatment. The risks of diabetes were compared between
different new OAC users using propensity score-weighted cumulative
incidence differences (CID).

L06.

Integrative Methodologies in Humans to Answer
Relevant Questions in Cardiovascular Sciences
David Montero, Assistant Professor 1, Meihan Guo, PhD Student 2
1
Li Ka Shing Faculty of Medicine, School of Public Health, Division of
Kinesiology, Institute of Cardiovascular Science & Medicine, The University
of Hong Kong, Hong Kong SAR
2
The University of Hong Kong, Hong Kong SAR

Results: There were 13,688 new users of OACs (warfarin: n ¼ 3454;
apixaban: n ¼ 3335; dabigatran: n ¼ 4210; rivaroxaban: n ¼ 2689). The
mean age was 75.0 (SD, 11.2), and 6,550 (47.9%) were women. After a
median follow-up of 0.93 years (interquartile range, 0.21-1.92 years), 698
incident diabetes cases were observed. In Cox-regression analysis, dabigatran use was signiﬁcantly associated with reduced risk of diabetes when
compared with warfarin use [HR 0.69 (95% CI 0.56-0.86; P < 0.001)], with
statistically insigniﬁcant associations observed for use of apixaban and
rivaroxaban. The corresponding adjusted CIDs at 2 years after treatment
with apixaban, dabigatran, and rivaroxaban users when compared with
warfarin were - 2.06% (95% CI - 4.08 to 0.16%); - 3.06% (95% CI - 4.79 to 1.15%); and - 1.8% (- 3.62 to 0.23%). In head-to-head comparisons between
women DOAC users, dabigatran was also associated with a lower risk of
diabetes when compared with apixaban and rivaroxaban.
Conclusions: Among adults with AF receiving OACs, the use of dabigatran had the lowest risk of diabetes when compared with warfarin use.

Physiology is the science of life: ‘How does the body work?’. The ultimate goal of any area of Physiology is to discover the fundamentals of
how a given function works, thus empowering to modify outcomes as
desired. Answers must be provided at multiple levels, starting from the
molecule up to the integration of organ function into the overall organism. While the prevailing emphasis on molecular biology is an
ineluctable consequence of technological prowess, sound integrative
bases of the cardiovascular system have yet to be elucidated in a large
fraction of the human population.
In this sense, comprehensive knowledge about Integrative Physiology is
essential for medical students. In this seminar, we will focus on the potential use of well-established integrative methodologies in humans to
answer relevant clinical questions in cardiovascular sciences. Our group
has made contributions regarding the interaction of blood volume, cardiac and metabolic capacities in healthy individuals, heart failure and
kidney disease patients. A myriad of questions remain to be elucidated in
current and upcoming collaborative projects in Hong Kong.

L05.

Association of Blood Pressure and Cardiovascular Disease
in Patients With Hypertension
Eric Wan, Assistant Professor 1
1
Department of Family Medicine and Primary Care, and the Department of
Pharmacology and Pharmacy of The University of Hong Kong, Hong Kong SAR

L07.

Using Sirna to Lower Cholesterol
Bernard MY. Cheung 1
Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics,
Department of Medicine, The University of Hong Kong, Hong Kong SAR

Introduction: While hypertension has been a recognized risk factor for
cardiovascular disease (CVD), there is currently no consensus on the
optimal blood pressure level for hypertension management. This
study revisits the controversy by evaluating the association between
blood pressure and CVD risk in two large general population cohorts.

1

Current lipid lowering guidelines suggest a LDL-C target, 1.4 mmol/L
for high cardiovascular risk persons, which is substantially lower than
2
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analyses using summary statistics obtained from the largest available
genome-wide association studies (GWAS) or GWAS meta-analysis of
depression (n¼500,199), broad depression (n¼322,580), CAD
(n¼184,305), MI (n¼171,875), stroke (n¼446,696) and AF (n¼1,030,836).
We found both depression phenotypes were genetically correlated
with MI (depression: r¼0.169; SE¼0.029; P¼9.03x10-9; broad depression: r¼0.123; SE¼0.032; P¼1x10-4) and AF (depression: r¼0.112;
SE¼0.025; P¼7.80x10-6; broad depression: r¼0.126; SE¼0.027;
P¼3.62x10-6). Genetically doubling the odds of depression was causally associated with increased risk of CAD (OR¼1.099; 95% CI: 1.0311.170; P¼0.004) and MI (OR¼1.146; 95% CI: 1.070-1.228; P¼1.05x10-4).
Doubling the odds of broad depression also increased risk of CAD
(OR¼1.099; 95% CI: 1.031-1.170; P¼0.004) and MI (OR¼1.146; 95% CI:
1.070-1.228; P¼1.05x10-4). Adjustment for blood lipid levels/smoking
status abolished the causal association of depression with CAD/MI.
Null causal association was observed for CVD on both depression
phenotypes. A similar pattern of results was observed in the secondary
analysis for broad depression. These suggest that genetic predisposition to depression may have positive causal roles on CAD/MI. Genetic
susceptibility to self-awareness of mood problems may be a strong
causal risk factor of CAD/MI. Blood lipid levels and smoking may
potentially mediate the causal pathway. Prevention and early diagnosis of depression are important in the management of CAD/MI.

previous targets. If the baseline untreated LDL-C is very high, then it is
not easy to attain LDL-C target using existing drugs, which include a
high-intensity statin, ezetimibe and perhaps a PCSK9 inhibitor. The
scene is therefore set for newer lipid lowering drugs that are well
tolerated and efﬁcacious. Inclisiran belongs to a new generation of
drug that uses RNA technology to induce prolonged and profound
lowering of LDL-C. It is a small interfering RNA that inhibits translation of the protein PCSK9. It can be injected once every six months,
thus ensuring good compliance. In clinical trials, it typically lowers
LDL-C by 40%. Some COVID-19 vaccines use RNA technology and
have shown to be safe and efﬁcacious in millions of patients, therefore
there should not be undue concerns about the safety of this new
technology. Inclisiran also lowers Lp(L), which is strongly associated
with cardiovascular risk. In conclusion, inclisiran represents a new
generation of lipid lowering drugs that can be added to the list of drugs
approved to lower LDL-C to target. The twice a year administration is
patient-friendly and some patients may prefer this over daily medications or monthly injections.
L08.

Emerging Role of Regulatory T Cells in Cardiovascular
Repair and Regeneration
Kathy Lui, Associate Professor 1
1
Department of Chemical Pathology, The Chinese University of Hong Kong,
Hong Kong SAR

L10.

Cardiomyocyte Terminal Differentiation,
Dedifferentiation, and the Centrosome

Accumulating evidence has demonstrated that immune cells such as
macrophages play an important role in the regulation of cardiovascular
repair. After injury, danger signals released by the damaged tissues
trigger the initial pro-inﬂammatory phase essential for removing
pathogens or cellular debris that is later replaced by the anti-inﬂammatory phase responsible for tissue healing. On the other hand,
impaired immune regulation can lead to excessive scarring and ﬁbrosis
that could be detrimental for the restoration of heart function. Regulatory T-cells (Treg) have been revealed as the master regulator of the
immune system that have both the immune and regenerative functions.
In this talk, we will summarize their regenerative role in directing cardiovascular repair and regeneration. The latter is clearly demonstrated
when Treg enhance the replication of neonatal cardiomyocytes after
injury facilitating functional heart regeneration. Moreover, we will also
discuss the molecular mechanism by which Treg could mediate cardiovascular repair through regulating the transcriptomic and epitranscriptomic events. Altogether, our ﬁndings may suggest some clinically
relevant insights into the development of Treg therapy targeting cardiovascular repair and regeneration in the future.

David Zebrowski, Assistant Professor 1
1
Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
SAR; Department of Medicine and Therapeutics, Lui Che Woo Institute of
Innovative Medicine; Centre for Cardiovascular Genomics and Medicine,
HK HOPE/Hong Kong Children’s Hospital, Hong Kong SAR
Mammalian cardiomyocytes become terminally differentiated shortly
after birth. Inducing dedifferentiation from their terminally differentiated state represents one strategy to restore proliferative potential
and achieve cardiac regeneration. To date little in known as to how
terminal differentiation occurs or, more so, when it begins. This is in
large part due to the absence of a cellular marker which enables one to
distinguish between non-terminally differentiated and terminally
differentiated cardiomyocytes. The centrosome is a solitary organelle
classically known as the primary microtubule organizing centre
(MTOC) of the cell. Proliferative, and regenerative, cardiomyocytes of
adult zebraﬁsh and newt have a centrosome. In contrast, mammalian
cardiomyocytes disassemble their centrosomes during perinatal
development. In this seminar, I will present data that supports the
centrosome as a bona ﬁde cellular marker with which to distinguish
terminally differentiated from non-terminally differentiated cardiomyocytes and how the centrosome enables detection of cardiomyocyte dedifferentiation from a terminally differentiated to a nonterminally differentiated state (i.e. to a state that possesses proliferative, and regenerative, potential).

L09.

Evaluation of Bi-Directional Causal Association Between
Depression and Cardiovascular Diseases: A Mendelian
Randomization Study
Gloria Li, Research Assistant Professor 1
1
Department of Health Technology and Informatics, The Hong Kong
Polytechnic University, Hong Kong SAR

L11.

Interplay Between Covid-19 and Cardiovascular Risk and
Disease

Depression and cardiovascular disease (CVD) are associated with each
other but whether their relationship is causal remains unclear. We
tested genetic correlation between two depression phenotypes [(i)
depression (primary analysis); (ii)broad depression (help-seeking for
problems with nerves, anxiety, tension or depression; secondary
analysis)] and CVD [including myocardial infarction (MI), stroke and
atrial ﬁbrillation (AF), but not coronary artery disease (CAD) as the
genetic correlation was previously conﬁrmed], followed by inferring
causality between the correlated traits by Mendelian Randomization

Donald Singer, President 1
1
Fellowship of Postgraduate Medicine
People with cardiovascular comorbidities are more likely to be infected
with SARS-CoV-2, especially those with hypertension, coronary heart
disease, diabetes mellitus and obesity. They are also more likely to
have worse outcomes from COVID-19, with similar associations in

3
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protein 1 target genes was inhibited by peroxisome proliferator-activated receptor alpha overexpression.
Conclusions: The present study reveals that endothelial peroxisome
proliferator-activated receptor alpha activation is effective to inhibit
vascular inﬂammation and atherogenesis, while inhibition of endothelial Yes-associated protein 1 activity may represent one of the potential mechanisms accounting for anti-inﬂammatory and
atherosclerotic beneﬁts of peroxisome proliferator-activated receptor
alpha agonists, thereby providing scientiﬁc support for the use of
ﬁbrates in patients with atherosclerotic vascular diseases (Supported
by HMRF 07181286 and SRFS2021-4S04).

reports for example from China, the USA and Italy. People with cardiovascular risk factors or established cardiovascular disease also
experience a high case-fatality rate from COVID-19. For example,
hypertension was reported in 40% of patients who died [odds ratio for
death, 3.05 (95% CI: 1.6–5.9)] in an early report of over 40,000 conﬁrmed
COVID19 patients in China. In the same report, cardiovascular disease
was associated with a 5-fold increase in risk of death from COVID-19.
Reasons for the synergy between cardiovascular risk and SARS-CoV-2
will be discussed as will the impact of effective vaccination and other
medical treatments on reducing severity of COVID-19 in these highrisk patients.
The involvement of policy makers is needed to complement the efforts
against COVID-19 of health professionals, regulators and the pharmaceutical and biotechnology industries. These efforts will not be
successful without also addressing the cardiovascular and other factors
that contribute to higher risk from COVID-19. Links to the severity of
COVID-19 make it all the more pressing for policy makers and public
health agencies to address underlying causes and to reduce the incidence and severity of preventable cardiovascular risk.

OP02.

Temporal Trends and Patterns of Infective Endocarditis
In a Chinese Population: A Population-Wide Study (2002 2019)
Mr. Hang Long Li 1, Ms. Yi Kei Tse 1, Mr. Si Yeung Yu 1, Ms. Lok
Yee Lam 1, Ms.
Kwan Yu Li 1, Mr.
Ka Lam Leung 1, Ms.
1
Nicole Wing Lam Hon , Mr. Pui Fai Wong 1, Ms. Shuk Yin Yu 1,
Dr. Kai Hang Yiu 1
1
The University of Hong Kong, Hong Kong SAR

Abstracts for Oral Presentations:
OP01:

The Role of Endothelial PPARα in Vascular Inﬂammation
and Atherogenesis

Objectives: The epidemiological and clinical characteristics of infective
endocarditis (IE) are known to exhibit substantial geographical variability but remain poorly understood in Asians. Therefore, we aim to
describe the epidemiological trends and clinical features of IE in Hong
Kong, and to identify the key contributors to death in IE patients in a
large Asian population.
Methods: We included all patients aged 20 or above newly diagnosed
with IE between January 1, 2002, and December 31, 2019, from a wellvalidated territory-wide database in Hong Kong. We studied the
incidence and one-year mortality of IE between 2002 and 2019 and
used interrupted time series to evaluate the change in incidence after
revision of antibiotic prophylaxis guidelines in 2007. Signiﬁcant contributors to 1-year all-cause death were identiﬁed using the population
attributable fraction (PAF). We used Poisson regression with propensity score matching to study the association of surgery with mortality over time.
Results: A total of 5,139 patients (60.418.2years, 37% women) were
included. The overall incidence of IE was 4.4 per 100,000 persons,
which did not change after the revision of antibiotic prophylaxis
guideline in 2007 (relative risk of change 0.85, 95% CI 0.64 to 1.14, P ¼
0.293). Patients with IE in 2019 were older and more comorbid than
those in 2002. There was a signiﬁcantly increasing trend in Methicillinresistant Staphylococcus aureus (MRSA), with an annual percentage
change of 4.2% (95% CI 1.9 to 6.6, P < 0.001). The one-year crude
mortality rate was 30% in 2002, which did not signiﬁcantly change over
time (P¼0.103). Between 2002 and 2019, the rate of surgery increased
and was consistently associated with a 45% risk reduction in 1-year allcause mortality (Hazard Ratio 0.55 [0.45-0.66], P < 0.001). Advanced age
(PAF 19%) and comorbidities (PAF 15%) were signiﬁcant contributors
to death, regardless of the time period.
Conclusions: We found that the incidence of IE remained stable between 2002 and 2019 in Hong Kong and was not inﬂuenced by the
revision of antibiotic prophylaxis guidelines. Over time, patients with
IE are increasingly older and more comorbid. Notably, the burden of
MRSA endocarditis increased, together leading to a dismal prognosis.
Despite rising surgery rates and associated substantial survival beneﬁts, the mortality of IE remained high. Taken together, our ﬁndings
provide important insights into the geographical disparities in epidemiological and clinical proﬁles of patients with IE, with several
important implications for health policymakers, researchers, and
clinicians.

Ms. Yujie Pu 1, Yu Huang, Professor 1, 2
1
School of Biomedical Sciences, The Chinese University of Hong Kong,
Hong Kong SAR
2
Department of Biomedical Sciences, City University of Hong Kong, Hong
Kong SAR
Objectives: Endothelial cell activation associated with dyslipidemia
initiates vascular inﬂammation and subsequent development of
atherosclerotic plaques. Peroxisome proliferator-activated receptor
alpha agonists are commonly used to treat patients with dyslipidemia,
and they may possess potential anti-inﬂammatory and anti-atherosclerotic properties. However, the mechanisms by which these agonists work against atherogenesis are largely unexplored. This study
aims to investigate the role of endothelial peroxisome proliferatoractivated receptor alpha in vascular inﬂammation and atherogenesis.
Methods: To examine the impact of endothelial peroxisome proliferator-activated receptor alpha on atherogenesis, pX601-AAVICAM2-sgRNA was used to knock down peroxisome proliferatoractivated receptor alpha speciﬁcally in endothelial cells of apolipoprotein E-deﬁcient mice on a western diet for 10 weeks, and the
peroxisome proliferator-activated receptor alpha agonist pemaﬁbrate
was orally administered during the last 2 weeks. To investigate the
beneﬁcial effect of peroxisome proliferator-activated receptor alpha in
endothelial cells, both viral vectors and pharmacological compounds
were used to control the peroxisome proliferator-activated receptor
alpha expression and activity in endothelial cells with and without
treatment of pro-inﬂammatory cytokines.
Results: The peroxisome proliferator-activated receptor alpha
expression and activation were suppressed in mouse aortic endothelial
cells with atherosclerotic plaques and 14-day oral administration of
pemaﬁbrate reduced the western diet-induced formation of atherosclerotic plaques and these beneﬁcial effects were abolished by
endothelium speciﬁc peroxisome proliferator-activated receptor alpha
knockdown. Both genetic overexpression and pharmacological activation of peroxisome proliferator-activated receptor alpha protected
endothelial cells against while peroxisome proliferator-activated receptor alpha inhibition augmented interleukine-1β- or tumor necrosis
factor α-induced inﬂammation. Furthermore, Yes-associated protein 1
phosphorylation was increased, and the expression of Yes-associated

4
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Results: Competing risk regression showed that hip fracture was
associated with increased one-year risk of major adverse cardiovascular events (hazard ratio, 1.27; 95% Conﬁdence Interval, 1.21 to 1.33;
p<0.001), with a 1-year cumulative incidence difference of 2.40%
(1.94% to 2.87%). The hazard ratio was the highest in the ﬁrst 90-day
after hip fracture (hazard ratio of 1.32), and such an estimate was
continuously reduced in 180-day, 270-day, and 1-year after hip
fracture.
Conclusions: Hip fracture was associated with increased immediate
risk of major adverse cardiovascular events. This study suggested that
a prompt evaluation of major adverse cardiovascular events among
older adults aged 65 years and older who are diagnosed with hip
fracture irrespectively of cardiovascular risk factors may be important,
as early management may reduce subsequent risk of major adverse
cardiovascular events.

OP03.

Trends in Cardiovascular Risk in the United States Over
Two Decades, 1999 – 2018
Mr. Hang Long Li 1, Bernard MY. Cheung, Professor 1
1
The University of Hong Kong, Hong Kong SAR
Objectives: As guidelines evolve, new drugs are introduced, and the
long-term trends in cardiovascular risk in the general population are of
interest. We evaluated the AHA-ACC-ASCVD risk score (CVDRS) in
the US in the 2 decades.
Methods: Non-pregnant participants in the National Health and
Nutrition Examination Survey (NHANES) 1999-2018 aged 40-79 years
were included. Temporal trends in CVDRS and its components, and
the proportions of raymondparticipants at high-risk (score 20%) were
characterized using linear regression, adjusted for age, sex, and
ethnicity. Data analysis was performed using the R package “survey”.
Results: Altogether 12744 participants (mean age 56.4 years; 55.9%
male) were analyzed (Table 1). The proportion of people with diabetes
and taking antihypertensives increased (both p<0.001), while total
cholesterol (TC) level decreased (p<0.001). Other components,
including high-density lipoprotein cholesterol and the proportion of
smokers, remained static.
From 1999 to 2018, the mean CVDRS signiﬁcantly increased from
11.40.7% to 12.50.5% (p¼0.014), and the proportion of high-risk
participants increased from 18.6% to 20.0% (p<0.001).
Conclusions: Cardiovascular risk in the US population increased
slightly in the past 20 years. Despite the increased treatment rate of
hypertension and the decrease in TC, the prevalence of diabetes
doubled. More effort should be directed at preventing diabetes
through weight control and regular physical activity.

OP05.

Instant Fabrication of Angiogenic Patch for Effective
Vascular Regeneration
Mrs. Thi Van Anh Bui 1, Dr. Kiwon Ban 1
1
City University of Hong Kong, Hong Kong SAR
Objectives: To investigate a novel protein patch that can deliver
effectively a cocktail of angiogenic factors for vascular regeneration
Methods: Firstly, the concentrations of chosen angiogenic factors,
including vascular endothelial growth factor, basic ﬁbroblast growth
factor, epidermal growth factor, insulin-like growth factor-1 were
optimized by migration and tube formation assay on endothelial cells.
Then, a combination of 4 factors at optimal concentrations was
compared the angiogenic effects with single and other combinations
by migration, tube formation, and proliferation assay. The cytoprotective effects of the combination on endothelial cells were also
examined. Parallely, droplet technique was employed to produce a
patch from sodium alginate and ε-poly-l-lysine. The patch was evaluated release kinetics of both small protein (Vascular endothelial
growth factor) by Enzyme-linked immunosorbent assay for 24 hours
and large protein (Bovine serum albumin) by Pierce bicinchoninic acid
protein assay for 72 hours. The released growth factors from the patch
were tested their function by migration assay. Adaptation of the patch
in vivo by encapsulating and releasing DiI in mouse legs was
measured by Spectrum In Vivo Imaging System. Therapeutic effects of
the patch are testing on hindlimb mouse models.
Result: The combination of angiogenic factors with 50ng/mL Vascular
endothelial growth factor, 20ng/mL basic ﬁbroblast growth factor,
10ng/mL epidermal growth factor, and 10ng/mL insulin-like growth
factor-1 showed the strongest angiogenic effects in vitro compared to
single factor and other combinations. It recruited the most migrated
endothelial cells, maintained the most tube-like structures, and highly
promoted cell proliferation. The combination of angiogenic factors
signiﬁcantly protected endothelial cells from ichemic injury induced
by H2O2 and inﬂammation injury induced by lipopolysaccharide.
Simultaneously, the patch demonstrated stable release kinetics with
both VEGF and BSA for 72 hours. The combination of angiogenic
factors encapsulated and secreted by the patch maintained good
function through migration effect. Patch encapsulating DiI slowly
released DiI to the muscle of the mice. DiI signal was detected and
increased from day 3 to day 15 after transplantation. Angiogenic factor
patch fully protected the ischemic hindlimbs from limb loss compared
to the control group.
Conclusion: Our patch strategy successfully deliver proteins to the
target tissue. The angiogenic patch indicated a novel approach for
vascular regeneration in cardiovascular disease treatment.

OP04.

Immediate Risk for Cardiovascular Events in Hip Fracture
Patients: A Population-Based Cohort Study
Mr. Warrington Wen Qiang Hsu 1, Dr. Chor-Wing Sing 1, Dr. Gloria
HY. Li 4, Kathryn CB. Tan, Professor 2, Bernard MY. Cheung,
Professor 2, Dr. Janus SH. Wong 3, Ian Chi-Kei Wong, Professor 1,
Dr. Ching-Lung Cheung 1
1
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong SAR;
2
Department of Medicine, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong SAR;
3
Department of Orthopaedics and Traumatology, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong SAR
4
Department of Health Technology and Informatics, The Hong Kong
Polytechnic University, Hong Kong SAR
Objectives: Emerging evidence showed that bone metabolism and
cardiovascular diseases are closely related. We previously observed a
potential immediate risk of cardiovascular mortality after hip fracture.
However, whether there is an immediate risk of cardiovascular events
after hip fracture is unclear. The aim of this study was to evaluate the
risk for major adverse cardiovascular events between patients having
experienced falls with and without hip fracture.
Methods: This retrospective population-based cohort study used data
from a centralized electronic health record database managed by Hong
Kong Hospital Authority. Patients having experienced falls with and
without hip fracture were matched by propensity score at a 1:1 ratio.
Adjusted associations between hip fracture and risk of major adverse
cardiovascular events were evaluated using competing risk regression
after accounting for competing risk of death.
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unclear of how PKD1 and PKD2 mutations could lead to cardiac disorders. We aim to elucidate the mechanisms of PKD1 and PKD2
involvement in cardiac disorders.
Methods: Human embryonic stem cells(hESC) were used to differentiate
cardiomyocytes (hESC-CM). HESC-CMs were knocked-down by AdPKD1& Ad-PKD2. 3D human ventricular cardiac tissues strip (3D-hvCTS)
was used to assess PKD1 & PKD2-associated functional abnormalities in
electrophysiological, Ca2+ handling and contractile properties.1
Results: On day 7, PKD1 & PKD2: knockdown hvCTS displayed lower
developed forces during both spontaneous contraction and electric
pacing-induced contraction at all pacing frequencies. Moreover, after
PKD1 & PKD2 knockdown, passive tension and total tension both
decreased. No difference was observed in the following parameters
between normal and PKD1/2 knockdown samples, including rise time
90, rise time 50, rise time 25, rise slope, max rise slope, AUC rise 90,
decay time 90, decay time 50, decay time 25 and AUC decay 90, decay
slope, max decay slope, beat rate variability and developed force
variability.
Conclusions: This study provides insight into the effects of PKD1 &
PKD2 knockdown on the contractility of hvCTS derived from hESCCMs. The decrease in developed force produced by PKD1 & PKD2
knockdown hvCTS recapitulate the cardiomyopathies in ADPKD patients in an in vitro model.

OP06.

Prognostic Value of a Novel Index: Computational
Pressure-Flow Dynamics Derived Fractional Flow Reserve
in Patients With Deferred Lesions
Ms. Kwan Yu Li 1, Ms. Lok Yee Lam 1, Mr. Ka Lam Calvin Leung 1,
Ms. Mei Zhen Wu 2, Ms. Qing Wen Ren 2, Ms. Shuk Yin Yu 1, Mr.
Pui Fai Wong 1, Ms. Yun Di Feng 3, Dr Yun Long Huo 3, Dr Kai
Hang Yiu 1
1
Division of Cardiology, Department of Medicine. The University of Hong
Kong, Queen Mary Hospital, Hong Kong, Hong Kong SAR
2
Division of Cardiology, Department of Medicine, the University of Hong
Kong Shenzhen Hospital, Shenzhen, China
3
PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China, Beijing,
China
Objectives: Computational pressure-ﬂow dynamics derived fractional
ﬂow reserve (caFFR) is a novel technique to determine the fractional
ﬂow reserve (FFR) without the use pressure wire or induction of
hyperaemia in conventional FFR. Previous studies have validated that
caFFR has high diagnostic accuracy in determining the functional
signiﬁcance of coronary lesions, compared to FFR. The aim of the study
is to evaluate its clinical implications in stable coronary artery disease
(CAD) with deferred lesions.
Methods: The study included a total of 340 patients (mean age 67.5 
10.7, 63.2% male) with 476 lesions in whom revascularization was deferred. Clinical events were compared according to lesion location and
caFFR categories: caFFR 0.65 (n¼46), caFFR¼ 0.66-0.8 (n¼34), caFFR¼
0.81-0.9 (n¼174), caFFR¼0.91-1.0 (n¼222) in lesion basis. The primary
endpoint was 3-year major adverse cardiac events (MACE), deﬁned as
a composite of death, myocardial infarction, or any unplanned
revascularization.
Results: The mean caFFR was 0.84  0.13 in 476 lesions. A total of 39
composite events occurred, including 23 death, 2 myocardial infarction
and 14 unplanned revascularization.
caFFR is an independent predictor for MACE (per 0.01 decrease;
adjusted hazard ratio [HR], 1.03; 95% conﬁdence interval [Cl], 1.011.04; P<0.01) and death (per 0.01 decrease; adjusted HR, 1.03; 95% Cl,
1.01-1.04; P<0.01). Following multivariable adjustment, the risk of
MACE was the highest in lesions with caFFR 0.65 (adjusted HR, 4.29;
95% Cl, 2.18-8.45; P<0.01) using caFFR¼0.91-1.0 as reference, followed
by caFFR¼0.66-0.8 (adjusted HR, 3.57; 95%Cl, 1.70-7.47; P<0.01). The
risk of MACE was similar in lesions with caFFR> 0.8.
In proximal lesions, caFFR remained an independent predictor for
MACE (per 0.01 decrease; adjusted HR, 1.04; 95% Cl, 1.03-1.06; P<0.01).
Such relationship was nonetheless not observed in distal lesions.
Conclusions: In stable CAD patients, haemodynamically signiﬁcant
lesions have lower caFFR, and higher risks of adverse outcomes. This
non-wire-based index, caFFR showed high clinical applicability in
quantifying myocardial ischemia, and improving risk prognostication
in deferred lesions.

PP02.

Role of TRPC5 in Endothelium-Dependent Contraction in
Hypertensive Model of Mice
Ms. Xiao Li 1, Mr. Chun-Yin Lo 1, Mr. Chi-Wai Lau 1, Xiaoqiang Yao,
Professor 1
1
Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
SAR
The augmented endothelium-dependent contraction (EDC) can stimulate the production of contractile prostanoids, which contribute to
endothelial dysfunction and hypertension. Furthermore, it is well
known that EDC plays a more prominent role in hypertension. The EDC
is Ca2+-dependent. However, the molecular identity of endothelial
Ca2+ channels that regulate EDC is not well studies. In a previous study,
we reported that endothelial cell transient receptor potential channel C5
(TRPC5), a Ca2+ -permeable channel, contributes to the EDC response
by stimulating cyclooxygenase 2 (COX-2) activity in the carotid arteries
of healthy mice. In the present study, I explored the molecular identities
of Ca2+-permeable channels that stimulate EDC in hypertensive model.
Mouse model of hypertension was established by subcutaneous infusion of angiotensin II and Nω-nitro-l-arginine (L-NNA). Systolic, diastolic and mean blood pressures were recorded by tail-cuff method.
ACH-induced EDC was detected by wire myograph in the presence of
NG-nitro-L-arginine methyl ester (L-NAME). [Ca2+]i was measured by
a Ca2+-sensitive ﬂuorescence dye. Results showed that ACH-induced
EDC in carotid arteries was reduced by TRPC5, TRPV4 and Orai1 inhibitor in a dose-dependent way. ACH resulted in the contraction which
could be abolished by a selective TP receptor antagonist. Besides, the
increased EDC under hypertension condition was also reversed by
these inhibitors. The ﬁndings suggest important roles of several endothelial Ca2+-permeable channels, TRPC5, TRPV4 and Orai1, in EDC
under hypertension. In future, it will be worthwhile to explore the
possibility of developing TRPC5/TRPV4/Orai1-based therapeutic options against EDC and hypertension.

Abstracts for Poster Presentations:
PP01.

PKD1 and PKD2 Associated Cardiomyopathies in 3D
Engineered Cardiac Tissue Model
Ms. Jingxuan Li 1, Dr. Yao Xiaoqiang 1
1
Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
SAR

PP03.

Association Between SGLT2 Inhibitors vs DPP-4
Inhibitors and Risk of Pneumonia Among Patients With
Type 2 Diabetes

Objective: Autosomal dominant polycystic kidney disease (ADPKD) is
a well-known genetic disease. It is caused by mutations in either polycystin-1(PKD1) or polycystin-2(PKD2). Cardiovascular complications
caused by this disease result in many deaths. However, it is still
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95%CI, 0.22-0.66). Compared to those taking hydrochlorothiazide monotherapy, patients with ﬁxed-dose combination therapy (OR, 0.33; 95%
CI, 0.22-0.49) had a signiﬁcantly lower risk of hypokalemia. Among those
taking potassium supplements simultaneously, 27.2% and 18.0% of patients treated with monotherapy and polytherapy had hypokalemia.
Conclusions: The prevalence of hypokalemia among hydrochlorothiazide users was alarmingly high. Women, ethnic minorities, and participants taking monotherapy were more likely to have hypokalemia.
Among those taking potassium supplements, up to 27% had hypokalemia. Regular monitoring of potassium and novel strategies to
reduce hypokalemia among hydrochlorothiazide users is urgently
warranted.

Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong SAR
2
Department of Medicine, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong SAR
Objectives: Sodium-glucose co-transporter 2 inhibitors (SGLT2is), the
latest class of glucose-lowering agents, have been gaining popularity in
recent years for their cardio-protective properties in addition to
glucose-lowering. Interestingly, SGLT2is were also shown to reduce
the risk of pneumonia in recent clinical trials. However, the real-world
effectiveness of SGLT2is on the risk of pneumonia is largely unknown.
The aim of the present study was to investigate the associations between SGLT2is use and the risk of pneumonia and pneumonia mortality compared to dipeptidyl peptidase-4 inhibitors (DPP4is) using an
electronic medical database in Hong Kong.
Methods: The present study was a retrospective cohort study. The
“prevalent new-user” design was adopted to account for the previous
exposure to the study drugs being compared. Propensity score (PS)
matching (1:4) was used to balance the baseline characteristics of the
two groups. Electronic health data of type 2 diabetes patients using
SGLT2is and DPP4is between 2015 and 2018 was collected from the
Clinical Data Analysis and Reporting System (CDARS). Primary outcomes were pneumonia incidence and mortality.
Results: The PS-matched cohort consisted of 6,664 users of SGLT2is
and 26,656 users of DPP4is, with a mean follow-up of 3.8 years. Poisson
regression showed that SGLT2is use was associated with lower risk of
pneumonia compared to DPP4is with an absolute rate difference of
3.78 per 1000 person-years (95% conﬁdence interval: 2.21-5.34). The
corresponding rate ratio was 0.75 (95% conﬁdence interval: 0.66-0.85).
Similar reduction in risk of pneumonia death was observed using
competing risk regression (hazard ratio: 0.60; 95% CI: 0.44-0.81).
Conclusions: Compared to DPP4is, SGLT2is use was associated with a
reduced risk of pneumonia and pneumonia mortality in a real-world setting.

PP05.

Systemic Arterial Hypertension and Chronic Obstructive
Pulmonary Disease: Dangerous Liaisons? Results from
the United States National Health and Nutrition
Examination Survey 1999-2018
Mr. Xiaopeng Liang 1, Mr. Oscar Hou In Chou 1, Dr. Ching
Lung Cheung 2, 3, 4, Bernard MY. Cheung, Professor 1, 2, 4
1
Division of Clinical Pharmacology and Therapeutics, Department of
Medicine, The University of Hong Kong, Hong Kong SAR
2
State Key Laboratory of Pharmaceutical Biotechnology, The University of
Hong Kong, Hong Kong SAR
3
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong SAR
4
Institute of Cardiovascular Science and Medicine, The University of Hong
Kong, Hong Kong SAR
Objectives: Systemic arterial hypertension (SAH) is one of the common comorbidities among patients with chronic obstructive pulmonary disease (COPD). This study aimed to investigate the association
between SAH and COPD.
Methods: 46,804 eligible non-pregnant participants aged  20 years
examined in Mobile Examination Center (MEC) of the National Health
and Nutrition Examination Survey (NHANES) 1999-2018 were included
in this study. Participants who had invalid data on covariates, SAH, and
COPD were excluded. The association between SAH and COPD was
studied using logistic regression, with adjustment for demographics,
body mass index (BMI), smoking, asthma, and diabetes status.
Results: Among the participants, 46.1% (95% CI, 45.3-46.9) had SAH
and 6.8% (95% CI, 6.4-7.2) had self-reported COPD. COPD was associated with SAH [OR¼1.71, 95% CI (1.56-1.88), P<0.01], which
remained signiﬁcant [OR¼1.16, 95% CI (1.03-1.31), P<0.01] after
adjusting for demographics, BMI, smoking, diabetes and asthma status. The association was found in women and adults aged less than 60
years in all models (All P<0.01). Furthermore, there was a signiﬁcant
association between SAH and COPD in current heavy smokers [1.27,
95% CI (1.01-1.61); P<0.01].
Conclusions: In this 20-year nationwide survey, COPD was associated
with SAH. The association was more robust among women and adults
aged less than 60 years. The association was more signiﬁcant among
heavy smokers. Our study demonstrates a need for hypertension
screening and blood control among COPD patients, especially heavy
smokers.

PP04.

Hydrochlorothiazide-Associated Hypokalemia: The
United States National Health and Nutrition Examination
Survey 1999-2018
Dr. Ziying Lin 1, Mr. Hang-Long Li 1, Bernard Man Yung Cheung,
Professor 1
1
The University of Hong Kong, Hong Kong SAR
Objectives: Hydrochlorothiazide is the most commonly used thiazide
diuretic for hypertension in the United States. Yet, hypokalemia is a
common adverse effect. A comprehensive update of the prevalence of
hypokalemia among users is warranted. We aim to evaluate the
prevalence and factors associated with hypokalemia among hydrochlorothiazide users.
Methods: Adults aged  20 years in the 1999-2018 National Health and
Nutrition Examination Survey were included. Participants were categorized according to the use of hydrochlorothiazide and other antihypertensive agents simultaneously. Using multivariable logistic
regression, we evaluated the factors associated with hypokalemia
(serum potassium < 3.5 mmol/L), including demographics and pattern
of prescription (monotherapy vs ﬁxed-dose combination therapy
[single pill containing hydrochlorothiazide and  1 other antihypertensive agent] vs polytherapy [> 1 antihypertensive pill]).
Results: A total of 4,314 hydrochlorothiazide users were identiﬁed. Hypokalemia was present in 12.6% of the hydrochlorothiazide users,
equivalent to approximately two million adults. Those who were women
[odds ratio (OR), 2.05; 95% conﬁdence interval (CI), 1.54-2.72] and nonHispanic black (OR, 1.54; 95%CI, 1.23-1.92) had a higher risk for having
hypokalemia. Younger and patients taking monotherapy were more
likely to develop hypokalemia. Compared to those aged 20-44 years,
those aged 80 years had a lower prevalence of hypokalemia (OR, 0.38;

PP06.

AMPK/miRNA-181B Axis Protects Against Diabetic
Endothelial Dysfunction
Dr. Chak Kwong Cheng 1, 2, Mr. Wenbin Shang 1, 2, Mr. Chi
Wai Lau 1, 2, Dr. Li Wang 1, 2, Yu Huang, Professor 1, 2
1
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2
Heart and Vascular Institute and Shenzhen Research Institute, The Chinese
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1.73 [1.57, 1.90], P value<0.0001), breast (HR: 1.36 [1.22, 1.51], P value<0.0001) and lung cancer (HR: 3.37 [3.11, 3.65], P value<0.0001).
Sulphonylurea users also had higher risks of cancer (HR: 2.38, 95% CI:
1.87-3.03;P<0.0001) and all-cause mortality (HR: 1.92, 95% CI: 1.78
-2.08;P<0.0001). Similar results were observed in the competing risk
and the sensitivity analysis.
Conclusion: Metformin demonstrated signiﬁcantly risk reduction and
mortality risks on cancer among type-2 diabetes patients compared to
sulphonylurea.

Objectives: Endothelial dysfunction is often the antecedent event of
diabetic vascular complications, such as diabetic retinopathy and
diabetic atherosclerosis. Previously, we reported that AMPK inactivation underlay endothelial dysfunction of diabetic mice. MicroRNA181b (miRNA-181b) was shown to improve vascular function and
suppress NF-κB activity in endothelial cells. However, it remains unclear about the upstream mediator of miRNA-181b, and whether the
activation of such signaling axis could protect against diabetic vascular
dysfunction. Therefore, the present study aimed to uncover the upstream mediator of miRNA-181b, and the presence of any physiological means for activating such signaling axis.
Methods: A diabetic mouse model was induced by high-fat diet feeding,
followed by streptozotocin (STZ) injection (6 mg/ml). Aortic endothelial
function of diabetic mice were evaluated by wire myography. ROS
levels in different arteries were measured by both dihydroethidium
(DHE) staining and lucigenin-enhanced chemiluminescence. Conventional biochemical assays, like Western blotting and RT-PCR, were
performed to study the signaling axis. Diabetic mice were subjected to
chronic running exercise on a rodent treadmill for 8 consecutive weeks
(45 min/day). In vitro simulation of blood ﬂow was performed by iBidi
ﬂow system to study the effect of shear stress on miRNA level.
Results: In the renal arteries of type 2 diabetic patients and aortae of
diabetic mice, miRNA-181b levels were remarkably downregulated. Coincubation of miR-181b mimics enhanced aortic vascular function, and
inhibited ROS over-production in different arteries from diabetic mice.
Furthermore, AMPK activation could boost miRNA-181b level in endothelial cells. Chronic exercise training increased miRNA-181b level by
AMPK activation. Importantly, in vitro simulation of exercise-induced
blood ﬂow increment was shown to ignite the AMPK/miRNA-181b axis.
Conclusions: Our ﬁndings suggested that AMPK/miRNA-181b axis
could protect against diabetic endothelial dysfunction. (The current
study was supported by RGC-SRFS, RGC-CRF and RGC-RIF.)
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Restored Autophagic Flux Improves Endothelial Function
in Diabetes via Decreasing Mitochondrial Ros-Mediated
Enos Monomerization
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Objectives: Endothelial nitric oxide synthase (eNOS) monomerization
and uncoupling are crucial mediators of vascular dysfunction in diabetes. Transcription factor EB (TFEB), a master regulator of autophagy
and lysosomal biogenesis, limits inﬂammation. Growing evidence indicates that autophagic dysregulation is involved in diabetic endothelial dysfunction, however, whether autophagy regulates eNOS
activity through controlling eNOS monomerization/dimerization remains elusive. The present study therefore aims to investigate whether
and how impaired autophagic ﬂux reduces eNOS activity and endothelial function through suppressed eNOS dimerization. Meanwhile,
we determine whether restoration of autophagic ﬂux through TFEB
induction, mTOR inhibition and calorie restriction can rescue the
impaired endothelial function in diabetic mice through restoring
eNOS dimerization.
Methods: The aortas of diabetic db/db mice and non-diabetic db/
m+ mice were used in ex vivo organ culture, functional study on
wire myograph and mitochondrial ROS (mtROS) production.
Western blotting was used to determine the level of protein of
target gene. Adenovirus was used to overexpress TFEB both in vivo
and in vitro.
Results: Autophagic ﬂux is impaired in the endothelium of db/db mice
and in human endothelial cells exposed to advanced glycation end
products or oxidized low-density lipoprotein. Pharmacological inhibition of autophagic ﬂux by chloroquine or baﬁlomycin A1 were sufﬁcient
to induce eNOS monomerization and lowered NO bioavailability
through increasing mtROS. By contrast, restoration of autophagic ﬂux
by TFEB overexpression reduced endothelial oxidative stress, enhanced
eNOS dimerization, and improved endothelium-dependent relaxations
(EDR) in diabetic mouse aortas. Meanwhile, inhibition of mammalian
target of rapamycin kinase (mTOR) by rapamycin increased TFEB nuclear localization, decreased mtROS accumulation, facilitated eNOS
dimerization, and improved endothelial function in db/db mice.
Furthermore, calorie restriction also increased aortic TFEB expression,
improved autophagic ﬂux, and restored EDR in diabetic mice.
Conclusion: The present study uncovers a causal relationship between
impaired autophagic ﬂux-induced mtROS accumulation and eNOS
dimer dissociation in diabetic endothelial dysfunction. Induction of
TFEB-driven autophagic ﬂux by inhibiting mTOR or through diet
intervention are effective to treat diabetic vasculopathy.
Keywords: Autophagy, TFEB, eNOS, endothelial dysfunction, diabetes
(Supported by RGC-CRF C4024-16W and RGC-SRFS2021-4S04)
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Xuejin Liu 1, Tong Liu, Professor 1, Wing Tak Wong,
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Objective: To investigate the effects of sulphonylurea compared to
metformin on the adverse outcomes of new-onset cancers and mortality risk among type-2 diabetes patients.
Methods: This is a retrospective population-based cohort study with
273876 type-2 diabetes patients followed from 1 January 2000 to 31
December 2019. Metformin or sulphonylurea users were matched
using a propensity score at 1:2 ratio to generate the control cohort. The
primary outcome was cancer events. Secondary outcomes were cancer,
cardiovascular, and all-cause mortality. Univariate Cox regression
models identiﬁed the associations of sulphonylurea and metformin
with adverse cancer and mortality outcomes. Competing risks were
considered with cause-speciﬁc hazard models and subdistribution
hazard models. Sensitivity analysis using different matching methods
of treatment weighting was conducted.
Results: A total of 36487 sulphonylurea and 71306 metformin users
were included in the matched cohort. Univariate Cox regression
showed that sulphonylurea users had higher risks of overall cancer
onset (hazard ratio [HR]: 2.26, 95% conﬁdence interval [CI]: 2.18-2.34,
P<0.0001), including pancreatic (HR: 4.03 [3.37, 4.82], P value<0.0001),
colorectal (HR: 2.12 [1.97, 2.27], P value<0.0001), genitourinary (HR:
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underlying mechanisms are incompletely known. Previous reports
showed that metformin reduced insulin resistance through activating
AMPK, while metformin has been recently described to suppress the
Hippo pathway effector YPA/TAZ through activation of AMPK. Our
previous study revealed YAP/TAZ activation promotes vascular
inﬂammation during atherogenesis. Therefore, we hypothesize that
metformin improves insulin sensitivity through AMPK-mediated
suppression of YAP/TAZ activity in vascular endothelial cells.
Methods: To investigate the role of YAP/TAZ in endothelial function
regulation under diabetic conditions, we measured endotheliumdependent relaxations in mouse arteries on myographs. The insulininduced vascular relaxation was used to determine insulin sensitivity
in mouse arteries. High glucose was used to mimic hyperglycemiainduced insulin resistance in diabetic patients. AMPK inhibitor compound C was used to indicate the involvement of AMPK in metformininduced improvement of insulin sensitivity and YAP phosphorylation.
The phosphorylation of YAP, AMPK, and eNOS was measured using
Western blot.
Results: Chronic treatment of metformin improved endotheliumdependent relaxations in the aortas from diabetic mice and dietinduced obese mice. The vaso-protective effect was reversed by AMPK
inhibitor. High glucose exposure impaired insulin-induced vascular
relaxations which can be reversed by metformin. Metformin reversed
high fat diet-induced suppression of AMPK phosphorylation in mouse
aortas. YAP overexpression impaired endothelium-dependent relaxations and this effect was reversed by metformin. Metformin
increased YAP phosphorylation, reversed high glucose-induced YAP
dephosphorylation, and elevated the expression of YAP target gene
CTGF in human umbilical vein endothelial cells (HUVECs). Moreover,
JNK phosphorylation is increased in high glucose-treated HUVECs,
which was reversed by metformin. Metformin also increased insulininduced eNOS phosphorylation in high glucose-treated HUVECs.
Conclusions: The present study reveals that metformin ameliorates
diabetes and obesity-associated endothelial dysfunction and improves
insulin sensitivity at least in part via suppressing YAP-JNK-inﬂammation pathway. Metformin suppresses YAP activity through AMPKmediated YAP phosphorylation. These new ﬁndings indicate a signiﬁcant role of YAP signaling in the regulation of vascular homeostasis
and YAP can serve as a useful target for therapeutic intervention for
restoration of endothelial function and insulin sensitivity in obesity
and diabetes (supported by RGC - C4024-16W, 14164817, SRFS20214S04, and HMRF 05161746).
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Objectives: Our previous studies showed that endothelium-speciﬁc
knockdown of YAP can delay the formation of atherosclerotic plaques,
indicating YAP serving as a new target for anti-atherosclerotic treatment. After screening a large number of drugs, we found that CBL0137,
a non-genotoxic anti-cancer drug, can signiﬁcantly inhibit the activity
of YAP in endothelial cells. However, whether CBL0137 has anti-inﬂammatory and anti-atherosclerotic effects is still unknown. The
present study investigates how CBL0137 regulates YAP to exert its
anti-inﬂammatory effects in vitro and in vivo. Also, we will explore
whether CBL0137 reduces formation of atherosclerotic plaques in
ApoE knockout mice.
Methods: Cell viability of HUVEC was determined by CCK8 assay.
Real-time PCR was used to detected YAP’s target gene and inﬂammation marker at mRNA level. The phosphorylation of YAP was
detected by western blotting. The anti-inﬂammatory effect of CBL0137
would be accessed by THP-1 monocytes attachment. ApoE knockout
mice were randomly divided into two groups (control group and
CBL0137 group) after partial carotid artery ligation. CBL0137 was
administered by intraperitoneal injection at 1 mg/kg/d. After 3 weeks,
the mice will be sacriﬁced. By comparing the percentage of plaque area
in the left common carotid artery to evaluate whether CBL0137 is antiatherosclerotic.
Results: CCK8 results showed that 1uM CBL0137 treatment for 24h did
not affect the activity of HUVEC. Dual luciferase reporter assay
showed that CBL0137 inhibited YAP (8GTIIC-luc reporter gene) activity. Real-time PCR results showed that CBL0137 signiﬁcantly suppressed the expression of YAP target genes (ANKRD1, CTGF, CYR61)
in both time- and concentration-dependent manner. CBL0137 reduced
the phosphorylation of YAP Y357 in HUVEC at 30 mins. CBL0137 can
inhibit IL-1β-induced inﬂammation in HUVEC. IL-1β (10 ng/ml) was
applied to induce endothelial inﬂammation and HUVECs were treated
with CBL0137. Both mRNA and protein levels of inﬂammation markers
(MCP-1, VCAM-1) were decreased after CBL0137 treatment. Monocyte
attachment results showed that CBL0137 (1 μM) inhibited IL-1βinduced monocyte inﬁltration. In the partial carotid artery ligation
model, the plaque area decreased from 70.9% to 50.4% after CBL0137
treatment for 3 weeks.
Conclusions: The present study provides new evidence that CBL0137 has
anti-inﬂammatory and anti-atherosclerotic effects by regulating YAP
phosphorylation. The speciﬁc mechanisms are being investigated (supported by RGC - C4024-16W, 14164817 and SRFS2021-4S04).
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Replacement for Severe Aortic Stenosis: A Prospective
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PP10.

Hippo Pathway Mediates the Beneﬁcial Effect of
Metformin Against Diabetic Endothelial Dysfunction and
Insulin Resistance

Objective: Severe aortic stenosis (AS) is the most common primary
valvular heart disease, treatable only by aortic valve replacement (AVR).
Current literatures have shown that severe AS may precede atrial
dysfunction which predicts adverse outcomes. However, predictive
value of pre-operative left atrial (LA) function on post-AVR clinical outcomes is uncertain. The study aims to evaluate the prognostic value of
pre-operative LA strain on post AVR all-cause mortality and heart failure.
Methods: Patients aged 18 years old or above with severe AS were
recruited and assessed using speckle-tracking echocardiography preoperatively. Severe AS was deﬁned according to 2014 AHA/ACC
Guideline for the Management of Patients with Valvular Heart

Dr. Li Jing Kang 1, Dr. Li Wang 1, 2, Yu Huang, Professor 1, 2
1
School of Biomedical Sciences, The Chinese University of Hong Kong,
Hong Kong SAR
2
Department of Biomedical Sciences, City University of Hong Kong, Hong
Kong SAR
Objectives: Metformin is the ﬁrst-line anti-diabetic drug. The pleiotropic beneﬁcial effects of metformin have been reported; however, the
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treated NRCMs compared with 32.912.27% in H2O2-treated controls;
Live/Dead assay stained and quantiﬁed much more live cells and LDH
assay suggested less cellular damage after extracts treatment.
Furthermore, extracts markedly decreased cellular ROS intensity
evaluated in microplate reader system (98247 in DCM-treated and
93335 in EA-treated cells compared with 229240 in H2O2-treated
controls). This result was further evidenced via ﬂowcytometry, which
indicated less DCF+ cells after treatment. For in vivo myocardial I/R
injury model, extracts-administrated rat hearts exhibited signiﬁcantly
larger viable myocardium and smaller infarct size.
Conclusions: Collectively, our in vitro and in vivo results suggested
maple tree leaf (Acer tataricum subsp. Ginnala) extracts possess signiﬁcant antioxidative potency and therapeutic effects against
myocardial I/R injury.

Disease. Peak Atrial Longitudinal Strain (PALS) was measured as a
surrogate of LA function. Patients with underlying pre-operative atrial
ﬁbrillation, other moderate to severe valvular heart diseases and
cancers were excluded. High PALS was deﬁned as PALS higher than
15.94%. Patients were followed up until death or end of the study. The
primary endpoint is a composite endpoint of all-cause mortality and
heart failure during hospitalization. The association of LA function
with composite endpoint of all-cause mortality and heart failure was
evaluated by Cox Proportional Hazards analysis.
Results: A total of 128 patients (mean age 65.3.9±9.4 years, 56.3% male)
were analyzed. Patients were followed up for a mean period of 3.9 
2.4years. A total of 65 of 128 patients (50.8%) belonged to low PALS
group. During the study period, 23 patients developed events on the
composite endpoint. Among those with composite endpoint, low PALS
group accounted for 18 (78.3%) patients and high PALS group
accounted for 5 (21.7%) patients. Higher PALS was independently
associated with lower risk of composite endpoint of all-cause mortality
and heart failure (HR, 0.33; 95% CI 0.117-0.916, p¼0.03) after adjustment for EuroSCORE II.
Conclusion: Higher PALS, a surrogate of LA function, is associated with
a lower risk of composite endpoints of mortality and heart failure in
patients with severe AS undergoing AVR, independent of EuroSCORE
II. Evaluation of LA function by assessing speckle tracking derived
PALS may aid in prognostication for patients undergoing AVR.
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Objectives: The circadian clock and rhythmicity regulate cardiovascular function and energy homeostasis. PER2 (period 2) is a key
circadian regulator. SIRT1 (sirtuin 1) is a longevity regulator. Crossregulation between PER2 and SIRT1 plays an important role in
modulating circadian rhythmicity. The present study investigated the
cardiac function of mice with a PER2 mutation (PER2MUT) and/or
human SIRT1 overexpressed selectively in endothelial cells (eSIRT1).
Methods: Male wild type (WT), PER2MUT, eSIRT1, or litters of
PER2MUT/eSIRT1 cross-breeders at the age of 34-weeks were used for
the present study. Cardiac function was evaluated by the Doppler Flow
Velocity system (Indus Instruments, Texas, USA).
Results: PER2MUT exhibited increased E-A peak velocity ratio (2.49 
0.90) when compared to WT (1.35  0.07), eSIRT1 (1.76  0.06) and
PER2MUT/eSIRT1 (2.03  0.39) mice. PER2MUT also showed
increased Isovolumic Contraction Time (34.75 4.25 millisecond) when
compared to WT (14.5  5.72 millisecond), eSIRT1 (13.85  3.07 millisecond) and PER2MUT/eSIRT1 (21.17  6.05 millisecond) mice. Isovolumic Relaxation Time was 26.25  5.13, 25.3 1.91, 30.94  9.06 and
29.92  20.61 millisecond, whereas E-linear Deceleration Time was
48.57 19.95, 35.95  3.0, 16.6  7.15 and 27.45  1.82 millisecond, in
WT, eSIRT1, PER2MUT and PER2MUT/eSIRT1 respectively.
Conclusion: Deletion in the Per-Arnt-Sim domain of the Per2 gene
resulted in diastolic dysfunction in PER2MUT mice, which was
attenuated by overexpression of SIRT1 in endothelial cells. The project
was supported by the grants from Seeding Funds for Basic Research of
the University of Hong Kong, the General Research Funds (17124718)
and Collaborative Research Funds (C7037-17W) of Research Grant
Council, the Areas of Excellence Scheme (AoE/M-707/18) of University
Grants Committee.
Keywords: PER2, Mitral Inﬂow, Diastolic Dysfunction, Endothelial
SIRT1

Maple Tree Leaf (Acer Tatarium subsp. Ginnala) Extracts
Confer Cardioprotection Against Myocardial Ischemia/
Reperfusion (I/R) Injury Through Signiﬁcant
Antioxidative Potency
Mr Aoyang Pu 1, Ms Yuen Kei Liem 1, Dr. Kiwon Ban 1
1
City University of Hong Kong, Hong Kong SAR
Objectives: Recent studies suggested Ginnalin A extracted from maple
tree leaf (Acer tataricum subsp. Ginnala) exhibited strong antioxidative
and therapeutic activities in various systems, we therefore investigated
whether maple tree leaf extracts can protect cardiomyocytes and heart
tissues against myocardial ischemia/reperfusion (IR) injury via antioxidative efﬁcacy.
Methods: Maple tree leaf (Acer tataricum subsp. Ginnala) from Korea
were harvested and extracts were prepared using ﬁve organic solvents
and their cardioprotective potentials were investigated in vitro and in
vivo using cardiac muscle cells and a rat myocardial IR injury model,
respectively. By 30min co-treatment or 1hr pre-treatment of extracts
with H2O2 in H9C2 myoblasts and neonatal rat cardiomyocytes
(NRCM), CCK-8 assay was employed to evaluate cell viability against
oxidative damage, which was further validated via LIVE/Dead assay
and lactate dehydrogenase (LDH) assay. In this cellular injury model,
DCFDA assay was also performed using microplate reader and ﬂowcytometry to determine and quantify the total cellular reactive oxygen
species (ROS) level, which mediated most of muscle damage during
reperfusion. To examine in vivo effect, 10min intramyocardial
administration of extracts before reperfusion was performed in rat
myocardial I/R model. 24hr after perfusion, hearts were collected and
sectioned then Evan's blue- and 2,3,5-triphenyltetrazolium chloride
(TTC) staining was applied to assess viable myocardium area and
infarct size.
Results: Maple tree leaf extracts were prepared and fractioned successively via ethanol, hexane (HX), dichloromethane (DCM) and ethyl
acetate (EA). After screening a series of concentration, DCM-fractioned
and EA-fractioned extracts at the concentration around 46.8μg/ml and
128.7μg/ml, respectively, signiﬁcantly improved survival of H9C2
myoblast and NRCMs against H2O2 in both 30min co-treatment and
1hr pre-treatment cell injury model: CCK-8 assay showed enhanced
cell viability to 73.315.45% in DCM-treated and 69.094.36% in EA-
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Clinical Signiﬁcance of a Novel Angiographic-Based
Index in Non-Culprit Vessels Among Patients Presenting
With Acute Coronary Syndrome and Concomitant
Multivessel Disease
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for competing risks, with death considered a competing event for HF
hospitalization. The incremental value of the biomarkers to EuroSCORE II and STS Score was evaluated using Harrell's C-statistic.
Results: Over a median follow-up of 3.9 years, 35 adverse events (22 HF
hospitalizations and 13 deaths) occurred. Elevated concentrations of
each biomarker were independently associated with long-term
adverse events after adjustment for demographics, comorbidities, and
echocardiographic characteristics (p<0.05 for each).
According to the biomarker score, 70 (54%), 40 (31%), and 20 (15%) patients were classiﬁed as low (0), intermediate (1-2), and high (3-4) risk,
respectively. Patients with higher biomarker scores were older, had
greater comorbidity burden, worse eGFR, and higher EuroSCORE II and
STS score (Ptrend <0.05). The risk of death (Hazard Ratio [HR], 3.27, 95%
CI 1.72-6.21), HF hospitalization (Subdistribution HR [sHR] 2.92, 95% CI
1.70-5.02), and adverse outcomes (HR 3.56, 95% CI 2.27-5.59) increased in
a graded fashion across biomarker score groups, with scores of 3-4
incurring the highest event risk. The biomarker score (sHR 2.61, 95%
Conﬁdence Interval [CI] 1.50-4.53, p<0.01), but not EuroSCORE II (sHR
1.05, 95% CI 1.00-1.10, p¼0.06) nor STS score (sHR 1.06, 95% CI 0.94-1.20,
p¼0.35), was independently predictive of HF hospitalization.
The addition of the biomarker score to EuroSCORE II and STS score
improved outcome prediction (C-statistic 0.78 vs 0.71, and 0.72 vs 0.61
respectively; likelihood ratio test p<0.001). Results were consistent
across combinations of valvular lesions.
Conclusions: In patients undergoing double valve surgery, a novel
biomarker-testing strategy comprising NT-proBNP, hs-cTnT, GDF-15,
and galectin-3 may improve risk assessment beyond conventional
risk-scoring systems.

Objectives: Computational pressure-ﬂow dynamics derived fractional
ﬂow reserve is a novel angiographic-based index used to assess the
severity of myocardial ischemia in patients with coronary artery stenoses, without the need of hyperemic stimulus and pressure wire
insertion. In patients with acute coronary syndrome, multivessel disease is often present, and the ischemia status of non-culprit vessels
may affect outcomes. In this study, we aimed to evaluate the clinical
value of the angiographic-based index in non-culprit vessels among
acute coronary syndrome patients with multivessel disease.
Methods: Patients presented with acute coronary syndrome and at
least two vessels with 50% diameter stenosis were included. The
culprit vessel was identiﬁed, and analyses of the angiographic-based
index of the non-culprit vessels were performed for every patient.
Based on the threshold of 0.8 adopted from fractional ﬂow reserve
studies, patients were stratiﬁed into ischemic group if the angiographic-based index was 0.8 in any non-culprit vessel, and into
non-ischemic group if none of the non-culprit vessels had the angiographic-based index 0.8. The primary endpoint was major adverse
cardiovascular events, deﬁned as a composite of all-cause mortality,
non-fatal myocardial infarction, and any subsequent revascularization.
Results: Our study included a total of 293 patients (mean age 65.313.2,
male 77.5%), with 113 (38.6%) presented with ST-elevation myocardial
infraction, 119 (40.6%) presented with non-ST-elevation myocardial
infarction, and 41 (14.0%) presented with unstable angina. Patients in
the ischemic group (n¼176) had more obstructive lesions in overall
compared to those in the non-ischemic group (n¼117) (3.81.5 vs.
3.21.1, p<0.001). The ischemic group patients had a higher rate of
primary endpoint at 3 years compared to non-ischemic group patients
(28.4% vs. 15.4%; adjusted hazard ratio, 1.92; 95% conﬁdence interval,
1.10-3.36; p¼0.023).
Conclusions: In acute coronary syndrome patients with concomitant
multivessel disease, myocardial ischemia in non-culprit vessels as
assessed by the novel angiographic-based index was associated with
adverse clinical outcomes at 3 years.
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Background: Dementia, in the setting of heart failure (HF), portends
poorer outcomes and poses great challenges in its clinical management.
Purpose: We investigated the incidence, types, clinical correlates, and
the prognostic impact of dementia in a population-based cohort of
patients with HF. Further, we examined the interactions of age and sex,
and education status with dementia incidence.
Methods: The previously validated Hong Kong Clinical Data Analysis
Reporting System (CDARS), a territory-wide database was interrogated to identify patients with HF (N¼ 202,121) from 1995 to 2018.
Associations of clinical correlates with incident dementia and its risk
with all-cause mortality were assessed using competing risk/multivariable Cox regression models where appropriate.
Results: Among a total cohort aged 18 years with HF (mean age:
75.313.0 years, 51.3% women), new-onset dementia occurred in 22,145
(11.0%) over a median follow-up of 5.5 years. Alzheimer’s disease
occurred in 27.0%; vascular dementia (18.1%) and unspeciﬁed dementia
(in 55.1%). Age-standardized rate of dementia incidence in women was
1297 (95%CI, 1276-1318) (vs. 744, 95%CI, 723-765) per 10000 population
in men. Other independent predictors of dementia include Increasing
age (HR 1.08), Female sex (HR 1.19), Nil/< primary (vs tertiary) education (HR 1.29), Parkinson’s disease (HR 1.73), head injury (HR 1.37),
peripheral vascular disease (HR 1.31), stroke (HR 1.29), depression (HR
1.18), alcohol intake (HR1.17), anaemia (HR 1.14), hypertension (HR
1.08), among other common comorbidities in HF (Figure 1A).
Notably, a signiﬁcant interaction (p<0.001) between age and sex on
dementia incidence was observed, such that women in all age groups
were observed to have higher sHR compared to men (Figure 1B). After
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Objectives: Risk stratiﬁcation in double valve surgery remains suboptimal due to a narrow focus on symptoms and left ventricular performance. Our study aims to evaluate the prognostic implications of a
biomarker-based risk score in double valve surgery.
Methods: A total of 130 patients (age 648 years, 49% female) presenting for concomitant aortic and mitral valve surgery underwent
echocardiography and measurements of N-terminal pro-B-type
natriuretic peptide, high-sensitivity cardiac troponin-T, growth differentiation factor-15, and galectin-3. An integer-based biomarker
score, with one point for each abnormal parameter, was developed
based on biomarker-speciﬁc thresholds deﬁned by penalized splines
and maximally selected rank statistics. The rates of adverse outcomes
(composite of heart failure [HF] hospitalization and all-cause mortality) were compared across biomarker score groups using Cox proportional hazards analysis. The Fine-Gray model was used to account
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these complications. This study aims to depict the outcomes of pregnancy among women with repaired TOF.
Methods: 105 pregnant episodes were identiﬁed among a cohort of 240
adult female patients with TOF from an electronic medical record system between 1990 to 2021. Echocardiographic studies from patients who
had received imaging within 1 year prior to and following delivery were
included. A paired sample t-test was carried out to compare echocardiographic parameters between pre-delivery and post-delivery periods.
For patients with a baseline of severe PR, linear regression was utilized
to highlight signiﬁcant changes in echocardiographic parameters.
Results: Among all pregnancies (n¼105), 65 successful pregnancies, 16
spontaneous-miscarriages, 21 termination of pregnancies and 3
ectopic pregnancies were identiﬁed. The mean maternal age was 28.9
(6.7) years with deliveries at 37.86 (30-41) gestational weeks and a
mean birth weight of 3.004 (1.705-4.050) kg. Most patients had natural
spontaneous deliveries (31.8%), followed by emergency lower section
cesarean section (LSCS) (29.5%), assisted delivery methods (18.2%),
elective LSCS (13.6%), and indicated LSCS (6.8%). Cardiovascular
events were found in 19 pregnancies with 4 patients experiencing
gestational hypertension, 4 patients with pre-eclampsia toxemia, 7
patients with heart failure symptoms and 4 patients with arrhythmias
(atrial tachycardia, ventricular tachycardia and ectopic beats). Other
complications involved 4 patients with gestational diabetes mellitus, 3
patients with impaired glucose tolerance, 2 patients with anemia, 3
patients with maternal thyroid disease and 1 patients with proteinuria.
Among the 65 successful deliveries, 7 patients received pulmonary
valve replacement before to their deliveries, 11 patients received pulmonary valve replacements after their deliveries. Echocardiographic
studies displayed signiﬁcant changes in left ventricular ejection fraction (LVEF) (Pre-delivery ¼ 60.69 8.73; post-delivery ¼ 59.39 9.36) (P
¼ 0.007), left ventricular end diastolic volume (LVEDV) (Pre-delivery:
89.71mL 18.22mL; Post-delivery: 80.96mL 12.32mL; P ¼ 0.007), left
end systolic volume (LVESV) (Pre-delivery: 35.43 12.36; Post-delivery: 32.70  8.83; P ¼ 3.7x10-5) and right ventricular index of
myocardial performance score (Pre-delivery: 0.34 0.12; Post-delivery:
0.33 0.12; P ¼ 0.007). Signiﬁcantly worse right ventricular global
longitudinal strain (RV GLS) (P ¼ 0.029) was detected in Patients with
severe PR.2 patients developed severe PR after delivery.
Conclusion: Adult female patients with TOF can have pregnancies
with acceptable mortality and morbidity, however intrapartum and
postpartum echocardiographic monitoring is advised.

accounting for competing risk, dementia was not associated with
adjusted hazard of all-cause mortality.
Conclusions: Female sex, lower socioeconomic status, increasing age
and common comorbidities were associated with higher hazards of
incident dementia.
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Objectives: Aspirin has been associated with reduction in incidence
and mortality of cancers. The prevalence of aspirin usage in cancer
patients in the general population is not well known. Therefore, we
investigated aspirin prescription in the U.S. population.
Methods: We analyzed data on 43,672 participants aged  20 years who
had valid data on cancer diagnosis status and prescription information
in NHANES 1999–2014.
Result: Among participants aged 20-39 years, 0.1% of participants took
aspirin and all of them were non-cancer participants. The total percentage increased with age, rising to 0.7% and 2.3% in participants
aged 40-59 years and above 60 years, respectively. The prevalence of
cancer increased with age from 2.1% in participants aged 20-39 years to
7.6% in participants aged 40-59 years and further to 22.5% in participants aged above 60 years.1.6% of cancer patients took aspirin, which
was signiﬁcantly higher than 0.8% for non-cancer participants
(OR¼2.17, 95%CI¼1.60-2.95, P<0.001). The difference was consistently
found in both men (OR¼2.55, 95%CI¼1.83-3.56, P<0.001) and women
(OR¼1.89, 95%CI¼1.20-2.99, P¼0.006).
Conclusions: Prevalence of both aspirin prescription and cancer were
found to be related to age increase. Aspirin is used in cancer patients
more than in non-cancer participants. Clinicians should keep in mind
the balance of aspirin’s beneﬁts and risks in different populations with
sex, age and individual assessment taken into consideration.
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Echocardiographic Assessment of Pregnant Women With
Tetralogy Of Fallot in Assessment of Outcome

Objectives: A substantial proportion of patients with acute coronary
syndrome (ACS) may have intermediate lesion(s) that are nonischemic during emergency coronary angiography. The long-term
prognosis of such patients, compared to stable ischemic heart disease
(SIHD), is uncertain. The role of PCI in such ACS patients remains
underexplored. Computational pressure-ﬂow dynamics derived fractional ﬂow reserve (caFFR) has been developed to assess myocardial
ischemia without invasive pressure wire and hyperemic stimulus. Our
aim is ﬁrst to assess the prognostic differences between ACS and SIHD
with non-ischemia intermediate lesions. Second, we ascertain whether
PCI in these ACS patients provides survival beneﬁt.

Ms. Wing Lam Nicole Hon 1, Ms. Bik Yu Louise Ting 1, Ms. Mei
Zhen Wu 1, Mr. Si Yeung Yu 1, Mr. Pui Fai Wong 1, Ms. Yi
Kei Tse 1, Mr. Hang Long Li 1, Mr. Lok Him Tsui 1, Ms. Shuk
Yin Yu 1, Mr. Kai Hang Yiu 1
1
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Objectives: Late complications of intracardiac repair of Tetralogy of
Fallot in adulthood include: impaired exercise performance, heart
failure, arrhythmia, and sudden cardiac death. Pregnancy may worsen
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further adjustment for age (men: OR¼1.015, 95%CI¼0.99-1.038,
p¼0.174; women: OR¼1.020, 95%CI¼0.997-1.044, p¼0.093).
Conclusions: Waist circumference was associated with hypertension in
our study. Waist circumference could be considered as a predictor for
the incidence of hypertension among Chinese population.

Methods: We studied 974 patients (mean age 65.1 years; male 61.9%)
with absence of myocardial ischemia, deﬁned as caFFR0.80 in all
vessels. Patients were stratiﬁed into those with ACS (n¼280) and those
with SIHD (n¼694). Among the ACS cohort, patients were divided into
those with PCI (n¼205) and with medical therapy (MT) (n¼75). The
SIHD cohort, all treated with MT, was considered as the referent
group. The primary endpoint was major adverse cardiovascular events
(MACE) at 3 years, deﬁned as a composite of all-cause mortality,
myocardial infarction (MI), and any revascularization.
Results: During a follow-up of 35.8 months, 136 MACE occurred,
including 97 all-cause mortality, 19 MI, and 32 revascularization.
Compared to SIHD, ACS was independently associated with MACE
even in the absence of myocardial ischemia (adjusted HR¼4.834; 95%
CI¼3.044-7.676; P<0.001). The 3-year incidence rate of MACE was the
highest in ACS patients with MT, followed by ACS patients with PCI;
SIHD patients had the lowest incidence rates (34.7% vs 23.4% vs 8.6%,
P<0.001). Similar ﬁndings were observed for hospitalization for allcause death (29.3% vs 16.6% vs 5.6%, P<0.001) at 3 years.
Conclusion: In patients with intermediate lesion(s) without myocardial
ischemia, those presented with ACS had a higher risk of MACE at 3
years compared to SIHD. In patients with ACS, our ﬁnding suggests
that PCI should be advocated to intermediate lesions even without
myocardial ischemia.
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Objectives: Metabolic disorders, such as diabetes mellitus and obesity,
represents a global health challenge. Endothelial dysfunction is one of
the earliest pathological events that triggers vascular oxidative stress,
inﬂammation and dysfunction, leading to the development of cardiovascular and metabolic diseases. To reduce the negative impact of high
sugar content in food and beverage on metabolic health, artiﬁcial
sweeteners have been widely consumed as food additives and generally considered beneﬁcial to health owing to their low caloric content.
The present study aims to evaluate the impact of chronic treatment
with sucralose on endothelial function in diet-induced obese mice.
Methods: Male C57BL/6J mice were fed with a 60 kcal% fat diet to
induce obesity and hyperglycemia. Some mice were treated orally with
sucralose (10 and 30 mg/kg/day, Sigma), dissolved in phosphate
buffered saline for 8 weeks. Serum levels of glucose and lipids were
measured. Acetylcholine (ACh)-induced endothelium-dependent relaxations of mouse mesenteric arteries were recorded on multi-channel myograph and en face accumulation of reactive oxygen species
(ROS) was measured in en face endothelial cells of mouse aortas using
dihydroethidium (DHE) staining.
Results: ACh-induced endothelium-dependent relaxations in mesenteric arteries were impaired in diet-induced obese mice and this
impairment was attenuated or reversed by sucralose treatment. Likewise, sucralose also rescued the impaired relaxation in response to
insulin in the same preparations. Chronic consumption of sucralose
was effective to normalize elevated endothelial ROS in obese mice.
However, 8-week sucralose treatment did not affect fasting blood
glucose level or body weight.
Conclusion: The present study shows that chronic sucralose treatment
results in beneﬁcial vascular effects to lower endothelial ROS production and to improve endothelial function in arteries of diet-induced
obese mice. The ongoing experiments will study the cellular mechanisms underlying the vaso-protective effect of sucralose (The present
study was supported by HMRF 06173956 and RGC - SRFS2021-4S04).
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Objectives: Recent evidence demonstrated an association between
waist circumference (WC) and hypertension. However, it remains
unclear whether such an association exists among Chinese population.
In this study, we investigated the relationship between WC and hypertension in Chinese population.
Methods: We included 2,265 participants (age18) from ShenzhenHong Kong United Network on Cardiovascular Disease (982 men and
1283 women; mean age SD 43.812.0). They had records on WC,
hypertension and other confounding factors. Difference in WC between hypertensive and normotensive subjects was evaluated using
Chi-square test. Multiple logistic regression was used to study the
association between WC and hypertension.
Results: 30.7% of participants have hypertension. WC of hypertensive
and normotensive were 86.59.4cm and was 80.49.9 cm respectively
(p<0.001). In overall population, there was a signiﬁcant association
between WC and hypertension before adjustment (OR¼1.063, 95%
CI¼1.053-1.074, p<0.001). The association remained signiﬁcant after
adjustment for age, smoking, alcohol consumption, physical activity,
hypercholesterolemia and sex (OR¼1.020, 95%CI¼1.004-1.036,
p¼0.015). In sex-speciﬁc analysis, association between WC and hypertension was observed in both men and women (men: OR¼1.035,
95%CI¼1.020-1.050, p<0.001; women: OR¼1.088, 95%CI¼1.071-1.104,
p<0.001) and it remained statistically signiﬁcant only in women after
adjustment for smoking, alcohol consumption, physical activity and
hypercholesterolemia (OR¼1.049, 95%CI¼1.026-1.072, p<0.001), but
not in men. No association was observed in both men and women after
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Objectives: Lipocalin-2 is a kind of pro-inﬂammatory adipokines that
is related to obesity-related cardiorenal syndrome (CRS). It has been
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Results: The blood pressure of control group signiﬁcantly increased by
ANS while no signiﬁcant changes were observed in the three groups of
antibody therapy. In WT mice without anti-lipocalin-2 treatment, PSR
staining showed that the kidney had typical glomerular and tubular
damages induced by ANS as well as heart turned to cardiac ﬁbrosis.
Combined with enzyme-linked immunosorbent assay results indicated that treatment with antibody against C87A signiﬁcantly attenuated diastolic dysfunction and cardiac injuries, whereas treatment with
antibody against R81E elicited more potent protective effects on renal
injuries induced by ANS.
Conclusion: Targeting the pathological forms of lipocalin-2 represents
a promising strategy for alleviating the progression of cardiorenal
syndrome.

suggested that lipocalin-2 and its disparate variants, C87A and R81E,
play a pathogenic role in the progression of the disease. This study
aims to evaluate the potential of different lipocalin-2 variants as biomarkers and drug targets for cardiovascular (CVD) diseases and
chronic kidney disease (CKD).
Methods: Neutralization antibodies targeting separately lipocalin-2
variants were administered to C57/BL6 mice during a six-week treatment with aldosterone and high salt after uninephrectomy (ANS). The
parameters of blood pressure, heart rate and body composition and
tissues weight were monitored for comparation. The heart and kidney
tissue samples were collected at the endpoint of study to perform
immunoassay and PSR staining. Twenty-four hours urine and serum
also immunoassay the concentration of the three lipocalin-2 variants.
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